![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NFU1 |
Gene summary for NFU1 |
![]() |
Gene information | Species | Human | Gene symbol | NFU1 | Gene ID | 27247 |
Gene name | NFU1 iron-sulfur cluster scaffold | |
Gene Alias | CGI-33 | |
Cytomap | 2p13.3 | |
Gene Type | protein-coding | GO ID | GO:0006790 | UniProtAcc | Q9UMS0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
27247 | NFU1 | P48T-E | Human | Esophagus | ESCC | 5.39e-22 | 3.58e-01 | 0.0959 |
27247 | NFU1 | P49T-E | Human | Esophagus | ESCC | 3.36e-14 | 1.31e+00 | 0.1768 |
27247 | NFU1 | P52T-E | Human | Esophagus | ESCC | 2.54e-22 | 4.94e-01 | 0.1555 |
27247 | NFU1 | P54T-E | Human | Esophagus | ESCC | 4.85e-15 | 3.72e-01 | 0.0975 |
27247 | NFU1 | P56T-E | Human | Esophagus | ESCC | 2.16e-05 | 8.89e-01 | 0.1613 |
27247 | NFU1 | P57T-E | Human | Esophagus | ESCC | 1.23e-23 | 5.16e-01 | 0.0926 |
27247 | NFU1 | P61T-E | Human | Esophagus | ESCC | 2.89e-14 | 3.65e-01 | 0.099 |
27247 | NFU1 | P62T-E | Human | Esophagus | ESCC | 2.92e-35 | 5.61e-01 | 0.1302 |
27247 | NFU1 | P65T-E | Human | Esophagus | ESCC | 3.53e-25 | 4.48e-01 | 0.0978 |
27247 | NFU1 | P74T-E | Human | Esophagus | ESCC | 6.55e-26 | 9.11e-01 | 0.1479 |
27247 | NFU1 | P75T-E | Human | Esophagus | ESCC | 1.08e-48 | 8.49e-01 | 0.1125 |
27247 | NFU1 | P76T-E | Human | Esophagus | ESCC | 1.34e-20 | 4.00e-01 | 0.1207 |
27247 | NFU1 | P79T-E | Human | Esophagus | ESCC | 6.06e-24 | 3.55e-01 | 0.1154 |
27247 | NFU1 | P80T-E | Human | Esophagus | ESCC | 2.00e-29 | 8.45e-01 | 0.155 |
27247 | NFU1 | P82T-E | Human | Esophagus | ESCC | 9.95e-07 | 6.35e-01 | 0.1072 |
27247 | NFU1 | P83T-E | Human | Esophagus | ESCC | 5.95e-27 | 7.50e-01 | 0.1738 |
27247 | NFU1 | P89T-E | Human | Esophagus | ESCC | 4.56e-25 | 1.56e+00 | 0.1752 |
27247 | NFU1 | P91T-E | Human | Esophagus | ESCC | 1.93e-09 | 1.19e+00 | 0.1828 |
27247 | NFU1 | P107T-E | Human | Esophagus | ESCC | 9.67e-30 | 6.93e-01 | 0.171 |
27247 | NFU1 | P126T-E | Human | Esophagus | ESCC | 1.43e-03 | 3.42e-01 | 0.1125 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005160418 | Esophagus | ESCC | protein maturation | 189/8552 | 294/18723 | 7.64e-11 | 2.39e-09 | 189 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:001622611 | Esophagus | ESCC | iron-sulfur cluster assembly | 21/8552 | 26/18723 | 2.69e-04 | 1.63e-03 | 21 |
GO:003116311 | Esophagus | ESCC | metallo-sulfur cluster assembly | 21/8552 | 26/18723 | 2.69e-04 | 1.63e-03 | 21 |
GO:009742811 | Esophagus | ESCC | protein maturation by iron-sulfur cluster transfer | 14/8552 | 16/18723 | 6.78e-04 | 3.56e-03 | 14 |
GO:00516046 | Liver | Cirrhotic | protein maturation | 121/4634 | 294/18723 | 3.54e-10 | 1.68e-08 | 121 |
GO:000679011 | Liver | Cirrhotic | sulfur compound metabolic process | 129/4634 | 339/18723 | 3.06e-08 | 1.04e-06 | 129 |
GO:000679021 | Liver | HCC | sulfur compound metabolic process | 212/7958 | 339/18723 | 5.60e-14 | 3.39e-12 | 212 |
GO:005160412 | Liver | HCC | protein maturation | 171/7958 | 294/18723 | 3.80e-08 | 8.30e-07 | 171 |
GO:0016226 | Liver | HCC | iron-sulfur cluster assembly | 18/7958 | 26/18723 | 5.37e-03 | 2.24e-02 | 18 |
GO:0031163 | Liver | HCC | metallo-sulfur cluster assembly | 18/7958 | 26/18723 | 5.37e-03 | 2.24e-02 | 18 |
GO:005160410 | Oral cavity | OSCC | protein maturation | 170/7305 | 294/18723 | 3.97e-11 | 1.28e-09 | 170 |
GO:00067905 | Oral cavity | OSCC | sulfur compound metabolic process | 168/7305 | 339/18723 | 4.50e-05 | 3.84e-04 | 168 |
GO:00162262 | Oral cavity | OSCC | iron-sulfur cluster assembly | 19/7305 | 26/18723 | 4.46e-04 | 2.70e-03 | 19 |
GO:00311632 | Oral cavity | OSCC | metallo-sulfur cluster assembly | 19/7305 | 26/18723 | 4.46e-04 | 2.70e-03 | 19 |
GO:0097428 | Oral cavity | OSCC | protein maturation by iron-sulfur cluster transfer | 11/7305 | 16/18723 | 1.56e-02 | 4.99e-02 | 11 |
GO:005160416 | Oral cavity | LP | protein maturation | 122/4623 | 294/18723 | 1.37e-10 | 7.72e-09 | 122 |
GO:00162261 | Oral cavity | LP | iron-sulfur cluster assembly | 15/4623 | 26/18723 | 3.34e-04 | 3.34e-03 | 15 |
GO:00311631 | Oral cavity | LP | metallo-sulfur cluster assembly | 15/4623 | 26/18723 | 3.34e-04 | 3.34e-03 | 15 |
GO:000679012 | Oral cavity | LP | sulfur compound metabolic process | 106/4623 | 339/18723 | 3.36e-03 | 2.25e-02 | 106 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NFU1 | SNV | Missense_Mutation | c.473N>T | p.Ser158Leu | p.S158L | Q9UMS0 | protein_coding | tolerated(0.11) | benign(0.027) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD | |
NFU1 | SNV | Missense_Mutation | c.516G>A | p.Met172Ile | p.M172I | Q9UMS0 | protein_coding | deleterious(0.03) | possibly_damaging(0.566) | TCGA-IR-A3LL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
NFU1 | SNV | Missense_Mutation | novel | c.748N>C | p.Glu250Gln | p.E250Q | Q9UMS0 | protein_coding | tolerated(0.14) | benign(0.003) | TCGA-VS-A958-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
NFU1 | SNV | Missense_Mutation | c.354C>A | p.Phe118Leu | p.F118L | Q9UMS0 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
NFU1 | SNV | Missense_Mutation | c.163N>T | p.Pro55Ser | p.P55S | Q9UMS0 | protein_coding | tolerated(0.56) | benign(0.001) | TCGA-AG-A00Y-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
NFU1 | SNV | Missense_Mutation | c.545N>A | p.Arg182Gln | p.R182Q | Q9UMS0 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-A5-A2K7-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | taxol | SD | |
NFU1 | SNV | Missense_Mutation | novel | c.328N>C | p.Lys110Gln | p.K110Q | Q9UMS0 | protein_coding | tolerated(0.06) | possibly_damaging(0.733) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
NFU1 | SNV | Missense_Mutation | c.339N>A | p.Phe113Leu | p.F113L | Q9UMS0 | protein_coding | deleterious(0.03) | possibly_damaging(0.859) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
NFU1 | SNV | Missense_Mutation | novel | c.143T>C | p.Leu48Pro | p.L48P | Q9UMS0 | protein_coding | tolerated(0.28) | benign(0) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
NFU1 | SNV | Missense_Mutation | novel | c.599N>T | p.Gly200Val | p.G200V | Q9UMS0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |